August 2-4, 2013 Hilton Orlando Orlando, FL

15  Download (0)

Full text

(1)
(2)

Continuing Education

The FSHP Annual Mee ng programming has been designed to enhance the knowledge, skills, and abili es of pharmacists and associated personnel in healthcare se ngs as we focus on important issues relevant to contemporary pharmacy prac ce.

TARGET AUDIENCE

The FSHP Annual Mee ng programs were developed to meet the needs of pharmacists and pharmacy technicians in a variety of prac ce se ngs. PHARMACIST GENERAL C.E. (GCE)

The Florida Society of Health‐System Pharmacists, Inc. is accredited by the Accredita on Council for Pharmacy Educa on as a provider of con nuing pharmacy educa on. The con nuing educa on programs for this mee ng are Applica on and Knowledge‐Based Con nuing Pharmacy

Educa on (CPE) ac vi es, which means that informa on that is provided will be in at least 60 minute lectures or presenta ons of facts that par cipants should be able to apply by means of learning assessment ques ons.

7.0 hours max of C.E. for Pharmacists and Pharmacy Technicians on Friday, August 8, 2014

 7.0 hours max of C.E. for Pharmacists and 8.0 hours max of C.E. for Pharmacy Technicians on Saturday, August 9, 2014 5.0 hours max of C.E. for Pharmacists and Pharmacy Technicians on Sunday, August 10, 2014

CONSULTANT RE‐CERTIFICATION (CRC) & *MEDICATION ERRORS C.E.

The Florida Society of Health‐System Pharmacists is approved by the Florida Board of Pharmacy as a provider of Consultant License Re‐

Cer fica on and Medica on Errors C.E. CE Broker Tracking # 20– 451995

6.0 hours max of CRC C.E. on Friday, August 8, 2014  2.0 hours of Medica on Errors on Friday, August 8, 2014

6.0 hours max of CRC C.E. on Saturday, August 9, 2014 4.0 hours max of CRC C.E. on Sunday, August 10, 2014 2.0 hours of Medica on Errors on Sunday, August 10, 2014

*The Medica on Errors C.E. will also count towards the required Pa ent Safety C.E. for PTCB Renewal.  CLAIMING C.E. CREDITS

Upon comple ng courses in their en rety, a endees will complete a Request for Con nuing Educa on form to verify a end‐

ance. Forms should be turned in to an FSHP representa ve upon leaving the mee ng. C.E. Statements will be available electron‐ ically 5‐6 weeks a er the conclusion of the program.

MEETING EVALUATION

FSHP would appreciate your feedback on mee ng sessions, speakers and other aspects of he mee ng. Immediately following the mee ng you will receive a link to evaluate the mee ng. We thank you in advance for your construc ve and appropriate

feedback.

Mee ng a endees must provide an NABP eProfile ID and month and date of birth to receive C.E. credits.

Sign up for your ID at www.nabp.net

PRESENTER DISCLOSURE STATEMENTS

FSHP requires faculty, planners and other individuals who are in a posi on to control the content of con nuing educa on ac vi es to disclose to

the audience any real or apparent conflict of interest related to the ac vity. All iden fied conflicts of interest are thoroughly reviewed by FSHP to

ensure fair balance, objec vity, and scien fic rigor in all educa onal ac vi es. FSHP maintains all disclosure informa on from all presenters of

FSHP sponsored educa onal programs, including speakers and poster abstract authors.

ACPE NON‐COMMERCIALISM STANDARD

The ACPE Standards for Commercial Support adopted in 2007 from ACCME require complete separa on of con nuing educa on and promo on. Instruc onal materials for C.E. ac vi es, including presenta on slides, undergo an intensive review process by FSHP to ensure compliance with

the Standards for Commercial Support. Disclosures of relevant financial interest by speakers have been included on slides or will be announced in

sessions, and in accordance with these Standards, any actual conflicts of interest were resolved prior to the C.E. ac vity taking place.

(3)

Schedule-At-A-Glance

Time

Session/Event

6:00am

5:00pm

Registra on Desk Open

6:00

7:00am

A endee Breakfast

7:15am

W

/G

S

7:35

8:35am

K

A

8:40

11:50am

S

C

T

11:50am

FSHP PAC Luncheon

11:50am

12:50pm

A endee

Lunch

11:50am

2:30pm

Exhibits Open

FR

IDA

Y

8T

H

SA

TURDA

Y

9T

H

Time

Session/Event

6:30am

5:00pm

Registra on Desk Open

6:00

7:00am

A endee Breakfast

7:00

8:00am

P

L

U

P

8:15

11:30am

I

D

T

8:15

11:30am

H

T

P

P

T

8:15

11:30am

I

T

T

11:00am

1:00pm

Poster Session

11:30am

Past Presidents’ Lunch

11:30am

12:30pm

A endee Lunch

11:30am

2:30pm

Exhibits Open

1:00

2:30pm

Residency Showcase

2:30

5:45pm

C

C

/E

M

T

2:30

5:45pm

I

M

/A

C

T

2:30

5:45pm

A

T

2:30

5:45pm

D

’ W

Session 1

Session 2

Session

3

2:30

5:45pm

C

/V

T

2:30

5:45pm

F

L

T

2:30

5:45pm

P

/P

M

T

5:30pm

Networking with Colleagues

 

(4)

Schedule-At-A-Glance

Time

Session/Event

_______________

All sessions on Sunday will be held in Room:

6:30am

A endee Breakfast

7:00am

12:45pm

Registra on Desk Open

7:00

8:00am

E

FORCSE

8:00am

FSHP Board Installa ons

8:15am

12:30pm

P

P

/E

O

T

   

Saturday, August 9th 

All student programming will be held in Room:

Time

Session/Event

________________

8:00

9:15am

Quiz Bowl

9:30

11:00am

Residency

Roundtables

11:00

11:30am

PPMI Update

2:30

3:30pm

You Are the Future: Steer Your Ship

3:30

4:30pm

Leadership

4:45

5:45pm

Career Panel

TEC

HNICIAN –

SPECIFIC SESSIONS

STUDENT

PR

OGRAMM

ING

SUNDA

Y

10T

H

Time

Session/Event

Friday, August 8th 

3:30

5:30pm

T

D

F

Saturday, August 9th 

All technician programming on Saturday will be held in Room:

8:15

10:30am

S

C

U

10:30

11:30am

S

H

H

M

1:30

2:30pm

N

U

D

2:30

3:30pm

C

3:30

4:30pm

I

P

4:45

5:45pm

M

D

6

(5)

7:15am WELCOME—E. Richard Kessler, Pharm.D., FSHP President

Moderator: E. Richard Kessler, Pharm.D.

7:35‐8:35am (1.0 hour of C.E. GCE/Tech) ACPE UAN 0163‐0000‐14‐166‐L04‐P and 0163‐0000‐14‐166‐L04‐T

  

   

KEYNOTE SPEAKER: STEVEN GRAY, PHARM.D., JD

Pharmacy Professional A

airs Leader, Kaiser Permanente, Na onal Pharmacy Programs and Services, Downey, CA

Presenta on Objec ves:



Describe the evolu on of pharmacy prac ce from product‐centered to pa ent‐centered.



Describe the various meanings of "Provider Status" for pharmacists.



Discuss the poten al impact of "Provider Status" on the pharmacy profession.



Describe the recent experience of the state of California in achieving “Provider Status” for pharmacists.



Provide guidance for pharmacists prac cing in the state of Florida to achieve “Provider Status”.

Moderator: Kathy Baldwin, Pharm.D., BCPS

8:40‐9:40am (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐167‐L04‐P and 0163‐0000‐14‐167‐L04‐T

USP 797 as it relates to prac ce in Florida  

Michele Weizer, Pharm.D., BCPS, Automa on Coordinator and CPOE Lead, JFK Medical Center/Vice Chair, Florida Board of Pharmacy, Atlan s, FL

Presenta on Objec ves:



Review the proposed updated 64B16‐27.797 revision (adop on of USP 797 and related chapters).



Differen ate between 503A and 503B (Iden fy those with federal oversight and explain Florida implica ons).



Discuss the impact of federal legisla on on office use compounding.

9:50‐11:50am (2.0 hours of C.E. GCE/CRC/Med Errors/Tech) ACPE UAN 0163‐0000‐14‐168‐L05‐P and 0163‐0000‐14‐168‐L05‐T

Reducing Medica on Errors Through Implemen ng a Con nuous Quality Improvement Program and Panel 

Bob Parrado, BPharm, RPh, Parrado Pharmacy Consultant, Tampa, FL

Presenta on Objec ves:



Define elements of a Con nuous Quality Improvement Program.



Restructure a pharmacy prac ce to address quality related events.



Explain how to conduct a root cause analysis of a quality related event.



Implement an ac on plan to address quality of care in pharmacies with a goal towards error reduc on and preven on.



Recite quality improvement regula ons for Florida pharmacies.



Implement programs to improve pa ent safety in pharmacy health care systems.

Panelists:

Michele Weizer, Pharm.D., BCPS, Automa on Coordinator and CPOE Lead, JFK Medical Center/Vice Chair, Florida Board of Pharmacy, Atlan s, FL

Bob Parrado, BPharm, RPh, Parrado Pharmacy Consultant, Tampa, FL

Ma hew Jenkins, Pharm.D., MS, Pharmacy Opera ons Manager, University of Virginia Health System, Charlo esville, VA Stephanie Basile, BS Psy, RPT, CPhT, Consultant, Omnicell, Columbia, SC

General Session and Keynote

Dr. Steven Gray has over 40 years of pharmacy experience, including military, hospital,

community, wholesaling, FDA registered compounding and managed care. He obtained a Doctor

of Pharmacy degree from the University of Southern California and a J.D degree from Northrop

University School of Law. He teaches pharmacy law and ethics and is currently the President

Elect

of the American Society for Pharmacy Law. In 2004, Dr. Gray served as president of the California

Pharmacists Associa on. In 2006 he served as President of the Na onal Associa on for Managed

Care Pharmacists, the Academy of Managed Care Pharmacy, and served on the Joint Council of

Pharmacy Prac

oners with the Presidents of APhA, ASHP, NCPA, and other na onal pharmacy

leaders. He is currently the Immediate Past President and Chair of the Board for the California

Society of Health

System Pharmacists. Steve is currently the Pharmacy Professional A

airs Leader for Kaiser

Permanente (KP), where he is responsible for coordina ng "Pre

Enactment Analysis and Ac vi es" regarding proposed

laws, regula ons and professional policies for KP's Na onal Pharmacy Programs and Services. He is a member of

several professional associa ons including AMCP, APhA, ASHP, CPhA, CSHP, and the California State Bar.

Frida

y, Augus

t 8, 2014

STERILE COUMPOUNDING TRACK

(6)

Moderator: Kathy Baldwin, Pharm.D., BCPS

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐169‐L01‐P

Thresholds, Targets and Approaches in Managing Hypertension: What’s New?  

David Parra, Pharm.D., FCCP, BCPS, Clinical Pharmacy Specialist, Cardiology, West Palm Beach VAMC, West Palm Beach, FL

Presenta on Objec ves:



Define hypertension.



List the appropriate steps in measuring blood pressure.



Describe addi onal methods to measure blood pressure other than office based measurements.



Summarize current blood pressure lowering recommenda ons and the data suppor ng them.



Recommend an appropriate medica on regimen based on current evidence.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐170‐L04‐P

Chronic Heart Failure Case through Transi ons of Care  

Shawn Anderson, Pharm.D., BCACP, Clinical Pharmacy Specialist, Cardiology, Department of Veterans Affairs, Gainesville, FL

Presenta on Objec ves:



Describe the impact of heart failure on morbidity and mortality.



Apply updated ACC/AHA guidelines for management of heart failure to pa ent care throughout the health care con nuum.



Discuss the role of an acute care pharmacist impac ng CMS core measures.



Recognize the impact of an ambulatory care pharmacist in reducing readmissions.

4:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐171‐L01‐P

Updates in An thrombo c Therapy  

Natalie Verbosky, Pharm.D., BCPS, Clinical Pharmacist, Cardiology Department, James A. Haley Veterans Affairs Hospital, Tampa FL Augustus (Rob) Hough, Pharm.D., BCPS, Clinical Pharmacy Specialist, WPB VA Medical Center, West Palm Beach, FL

Presenta on Objec ves:



Describe evidence based recommenda ons for various combina on an platelet regimens.



Appraise data available for the dura ons of dual an platelet therapies in various situa ons.



Discuss prac cal considera ons with use of an thrombo c therapies in the acute care se ng.



Detail current trends and future developments with the newer an thrombo c therapies.

Moderator: Kelly Biastre, Pharm.D.

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐172‐L04‐P and 0163‐0000‐14‐172‐L04‐T

On the Radar: Regulatory Basics  

Alissa Voils, Pharm.D., MSHA, Assistant Director, Inpa ent Opera ons, UF Health Shands Hospital, Gainesville, FL

Presenta on Objec ves:



Discuss key regulatory agencies, their scope, and objec ves.



Define common regulatory acronyms.



Discuss significance of regulatory compliance and how it applies to you.



Iden fy the most common medica on management regulatory compliance issues.



Review hospital and departmental survey readiness strategies.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐173‐L04‐P and 0163‐0000‐14‐173‐L04‐T

Business Side of Pharmacy Leadership: Proving Pharmacy Department Added Value 

Heath Jennings, Pharm.D., MBA, FASHP, BCPS, Director of Pharmacy, Florida Hospital, Orlando, FL

Presenta on Objec ves:



Demonstrate how pharmacy can achieve greater organiza onal value and provide meaningful return on investment.



Describe how to use business analy cs to show pharmacist value and impact on hospital opera onal costs.



Explain the importance of pharmacy inventory management and how to improve secondary to drug u liza on and formulary

control.



Present data to senior hospital administra on to garner support for new pharmacy services, programs, and personnel.

4:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐174‐L04‐P and 0163‐0000‐14‐174‐L04‐T

Naviga ng With Your Leadership Choices 

Peter D. Hurd, Ph.D., Professor/Department Chair, Pharmaceu cal and Administra ve Sciences, St. Louis College of Pharmacy, St. Louis, MO

Presenta on Objec ves:



Apply concepts and content from the session to their own leadership challenges.



Choose leadership strategies that are aligned with the characteris cs of the situa on and the needs of the organiza on.



Recognize when different leadership styles might be most appropriate for a given situa on.

Educational Sessions

Frida

y, Augus

t 8, 2014

CARDIAC/VASCULAR TRACK

ROOM:

FUTURE LEADERS TRACK

ROOM:

(7)

Moderator: Patricia Louzon, Pharm.D., BCPS

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐175‐L01‐P

Clinical Pearls: Depression, Bipolar, Sleep Disorders 

Karrie R. Jones, Pharm.D., BCPP, BCPS, Clinical Pharmacy Specialist, Mental Health, NF/SG Veterans Health System, Gainesville, FL

Presenta on Objec ves:



Iden fy current management op ons for bipolar disorder.



Design a treatment plan for pa ents with depression.



Discuss behavioral and pharmacologic treatment op ons for sleep disorders.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐176‐L01‐P

ADD/ADHD Across the Con nuum 

Andrea P. Dunn, Pharm.D., Clinical Pharmacist, Nemours Children's Hospital, Orlando, FL

Presenta on Objec ves:



Review diagnos c criteria for a en on deficit‐hyperac vity disorder (ADD/ADHD) based on the Diagnos c and Sta s cal

Manual of Mental Disorders, 5th edi on (DSM‐5).



Compare current treatments op ons approved for ADD/ADHD among children and adolescents.



Iden fy medica ons approved for adults with ADD/ADHD and review monitoring parameters.



Discuss treatment strategies to help adolescents with ADD/ADHD transi on into adulthood.

4:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐177‐L01‐P

Iden fying and Managing Pain in High Risk Pa ents 

Jose Rey, MS, Pharm.D., BCPP, Associate Professor, Nova Southeastern University, Ft. Lauderdale, FL

Presenta on Objec ves:



Iden fy pa ents at risk of opioid abuse.



Compare op ons for pain management in pa ents with history of opioid abuse.



Discuss considera ons and challenges of pain management in pa ents with concomitant disease states.

2:30‐5:45pm (3.0 hours of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐178‐L04‐P Presenta on Objec ves:



Discuss produc vity/metric repor ng for the health system pharmacy.



Understand directors’ experience complying with accredita on requirements.



Iden fy methods to enhance revenue in today’s health care environment.



Explore ways to be er use technicians in pharmacy opera ons.



Review the pharmacist provider status ini a ve and impact on hospitals.

SESSION 1 ROOM:

Facilitators:

Blanca R. Rivera, RPh, M.Pharm., MBA, Execu ve Director of Pharmacy Services for UHealth, University of Miami Hospital, Miami, FL Osmel Delgado, Pharm.D., MBA, FASHP, Senior Director of Opera ons, Cleveland Clinic, Weston, FL

SESSION 2 ROOM:

Facilitators:

John. Dougherty, MBA, Pharm.D., BCPS, Director of Pharmacy, Nemours Children’s Hospital, Orlando, FL Tim L’Hommedieu, Pharm.D., M.S., Director of Pharmacy, St. Joseph’s Hospital, Tampa, FL

SESSION 3 ROOM:

Facilitators:

Thanh Hogan, Pharm.D., Division Director, Ancillary Services, UF Health Jacksonville, Jacksonville, FL Peter Duggan, BS Pharm, Director of Pharmacy, Gulf Coast Medical Center, Ft. Myers, FL

Space is limited to Managers/Directors who indicated their interest in a ending during mee ng pre‐registra on.

Educational Sessions

Frida

y, Augus

t 8, 2014

PSYCHIATRY/PAIN

MANAGEMENT

TRACK

ROOM:

(8)

Moderator: Cher Enderby, Pharm.D., BCPS, BCNSP

7:00‐8:00am (1.0 hour of C.E. GCE/Tech) ACPE UAN 0163‐0000‐14‐179‐L03‐P and 0163‐0000‐14‐179‐L03‐T

Lawrence A. Gonzalez, Esq., General Counsel, Florida Society of Health‐System Pharmacists,

Troy Ba erton, Pharm.D., FCCM, Pharmacy and Legisla ve Representa ve, Florida Society of Health‐System Pharmacists

George Malone, Pharm.D., CPh, Senior Project Manager, Cardinal Health Innova ve Delivery Solu ons/FSHP L & R Affairs Council Chair Norman P. Tomaka, BS Pharm, MS, FAPhA, Consultant Pharmacist and Healthcare Risk Manager, Melbourne, FL/FSHP L & R Affairs Council Board Liaison

Presenta on Objec ves:



Discuss key bills related to pharmacy prac ce as presented for considera on to the Florida House and Senate during the 2014

legisla ve session.



Review issues centered on pa ent safety and pharmacy risk management involved with recently enacted Florida legisla on

related to the Chapter 465 of the Florida Statues (Pharmacy Prac ce Act).



Review regulatory considera ons related to pharmacist health care provider status.



Discuss evolving prac ce regula ons before the Florida Board of Pharmacy including sterile compounding.

Moderator: Jamie Kisgen, Pharm.D., BCPS

8:15‐9:15am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐180‐L01‐P

Microbiology 101: What You Wish You Had Learned in Pharmacy School 

Lindsey Childs‐Kean, Pharm.D., MPH, BCPS, Clinical Assistant Professor, University of Florida College of Pharmacy, Department of Pharmacotherapy and Transla onal Research, St. Petersburg, FL

Presenta on Objec ves: 



Compare and contrast the mechanisms of an microbial resistance.



Discuss suscep bility tes ng and how it impacts treatment.



Explain the role of an biograms in clinical prac ce.



Given a pa ent case, determine which an microbial agent(s) would be most effec ve for treatment.

9:15‐9:30am BREAK

9:30‐10:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐181‐L01‐P

Mixing it up with Polymyxins 

Bri any Fries, Pharm.D., BCPS‐AQID, Assistant Manager, Clinical Pharmacy Services, Arnold Palmer Medical Center/Orlando Health, Orlando, FL

Presenta on Objec ves:



Summarize the history of polymyxins.



Describe the pharmacokine c and pharmacodynamic proper es of polymyxins.



Compare and contrast available polymyxin compounds.



Discuss dosing prac ces and protocoliza on of polymyxins for adult and pediatric pa ents.



Explain the role of polymyxin monotherapy and combina on therapy.

10:30‐11:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐182‐L01‐P

IDSA & ICCAC: The Cliff Notes 

Yanina Pasikhova Pharm.D., BCPS‐AQID, AAHIVP, Clinical Pharmacist, Infec ous Diseases, Moffi Cancer Center, Tampa, FL

Presenta on Objec ves: 



Describe key studies presented at the most recent IDWeek and ICAAC mee ngs and their applica ons to clinical prac ce.



Discuss new research in the management of Clostridium difficile infec on.



Explain the role of combina on therapy in the empiric treatment of gram‐nega ve bacteria.

Educational Sessions

PHARMACY LAW UPDATE PANEL

ROOM:

INFECTIOUS DISEASES TRACK

ROOM:

Sa

tur

da

y, Augus

t 9, 2014

10

(9)

Sa

tur

da

y, Augus

t 9, 2014

Moderator: Lyndi McVey, Pharm.D., BCPS

8:15‐9:15am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐183‐L01‐P

Tips & Tricks to Managing and Monitoring Oral Chemotherapy 

Kourtney D. LaPlant, Pharm.D., BCOP, Clinical Oncology Specialist, NF/SG Veterans Health System, Gainesville, FL

Presenta on Objec ves:



Discuss fundamental monitoring parameters of oral chemotherapy.



Iden fy current trends in oral chemotherapy management for inpa ent and outpa ent se ngs.



Communicate challenges and opportuni es for improvement in transi ons of care.



Explore opportuni es for implemen ng a pharmacist driven oral chemotherapy monitoring program.

9:15‐9:30am BREAK

9:30‐10:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐184‐L04‐P

Back to the Future: Integra ng Pharmacogenomics into Pharmacy Prac ce 

Kris n Weitzel, Pharm.D., CDE, FAPhA, Associate Director, UF Health Personalized Medicine Program, Clinical Associate Professor, Pharmacotherapy and Transla onal Research, University of Florida College of Pharmacy, Gainesville, FL

Presenta on Objec ves:



Describe pa ent popula ons most suited for pharmacogenomic tes ng.



Compare and contrast currently available pharmacogenomic tests.



Provide guidance on how to incorporate pharmacogenomic tes ng results into contemporary pharmacy prac ce se ngs.

10:30‐11:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐185‐L04‐P

Be Prepared! Best Prac ces in Drug Shortages Management 

Deb Saine, MS, RPh, FASHP, Senior Lean Management Engineer, Valley Health System/Valley Physician Enterprise, Winchester, VA

Presenta on Objec ves:



Recognize current challenges in drug shortage management.



Determine systema c methodology for management of drug shortages.



Develop a communica on system for current status of drug shortages.

Moderator: Tara Higgins, Pharm.D.

8:15‐9:15am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐186‐L04‐P

What Pharmacists Can Learn from their IT Counterparts 

Eric Rose, Pharm.D., PMP, CHTS‐CP, Manager, Corporate Clinical Decision Support and Pharmacy Informa cs, IS Rela onship Manager for Quality and Acute EMR Governance, Clinical Informa cs, Orlando Health, Orlando, FL

Presenta on Objec ves: 



Discuss the basics of project management.



“Nerd transla on” – Understanding how IT folks think.



Describe useful and/or innova ve ways your IT systems can improve daily produc vity.

9:15‐9:30am BREAK

9:30‐10:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐187‐L04‐P

Diving into mHealth to Enhance Pa ent Engagement and Extend Pharmacy’s Role 

Kevin Clauson, Pharm.D., Associate Professor, Lipscomb University, Nashville, TN Presenta on Objec ves:



Outline core terminology and concepts within mobile health (mHealth).



Delineate the use of mHealth to enhance pa ent engagement and improve medica on adherence.



Explore opportuni es for mHealth tools and technology to extend the role of pharmacy.



Ar culate pi alls associated with use of mobile apps and devices.

10:30‐11:30am (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐188‐L04‐P

Delving Into Social Media 

Jeff Cain, EdD, MS, Adjunct Associate Professor, Director of Educa on Technology, University of Kentucky College of Pharmacy, Lexington, KY

Presenta on Objec ves:



Analyze the trends of social media use in the United States.



Discuss e‐professionalism issues within the healthcare environment.



Discuss the legal and ethical issues pertaining to social media in healthcare.

Educational Sessions

HOT TOPICS IN PHARMACY PRACTICE TRACK

ROOM:

(10)

Moderator: Abigail D. An gua, Pharm.D.

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐189‐L04‐P

Synthe c Drugs of Abuse 

Dawn R. Sollee, Pharm.D., DABAT, Assistant Director, Florida/USVI Poison Informa on Center, UF Health Jacksonville, Clinical Associate Professor, University of Florida, College of Pharmacy and Associate Professor, University of Florida, College of Medicine, Department of Emergency Medicine, Jacksonville, FL

Presenta on Objec ves:



Describe complica ons associated with u liza on of synthe c drugs of abuse.



Iden fy commonly used synthe c drugs of abuse in adult and pediatric pa ents.



Discuss key principles in the management of pa ents intoxicated with synthe c drugs of abuse.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐190‐L01‐P

NonVKA Oral An coagulants: Preven on & Treatment of Bleeding 

Stacy A. Voils, Pharm.D., MS, BCPS, Clinical Assistant Professor, Department of Pharmacotherapy and Transla onal Research, University of Florida College of Pharmacy, Gainesville, FL

Presenta on Objec ves:



Discuss evidence for reversal of an coagulant medica ons.



Compare and contrast clo ng factor concentrates commonly used for an coagula on reversal.



Use laboratory data to confirm successful reversal of an coagulants.



Provide an algorithm to control life threatening emergent bleeding in an coagulated pa ents.

4:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐191‐L04‐P

Society of Cri cal Care Medicine (SCCM) and American College of Emergency Physicians (ACEP) Mee ng Summary 

Nicole T. Reardon, Pharm.D., BCPS, Cri cal Care/Trauma Pharmacist Clinical Coordinator, Pharmacy Services, Ocala Health System Clinical Assistant Professor, University of Florida College of Pharmacy, Gainesville, FL

Katelyn R. Dervay, Pharm.D., BCPS, Pharmacotherapy Specialist‐Emergency Medicine, Director, PGY2 Emergency Medicine Residency Department of Pharmacy Services, Tampa General Hospital, Tampa, FL

Presenta on Objec ves:



Review opportuni es for involvement in focused specialty organiza ons like the Society of Cri cal Care Medicine (SCCM) and

the American College of Emergency Physicians (ACEP).



Discuss therapeu c updates from the 2014 SCCM Annual Congress in the areas of drug shortages, pulmonary hypertension,

delirium, alcohol withdrawal and stress ulcer prophylaxis.



Describe therapeu c updates from the 2013 ACEP Scien fic Assembly mee ng in areas of rapid sequence intuba on, top

ar cles of EM, and toxicology.



Apply mee ng updates and recent significant cri cal care and emergency medicine literature to pharmacy prac ce.

Moderator: Teresa Geide, Pharm.D., BCPS

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐192‐L04‐P

New Lipid Guidelines 

Kimberly Schnacky, Pharm.D., BCPS, Supervisor of Clinical Pharmacy Programs, Orlando VA Medical Center, Orlando, FL

Presenta on Objec ves:



Discuss the new 2013 American College of Cardiology/ American Heart Associa on (ACC/AHA) Lipid Guidelines and evidence

base for these updated recommenda ons.



Understand the new Pooled Cohort Equa ons to es mate 10‐year risk of atherosclero c cardiovascular disease (ASCVD).



U lize available risk assessment tools in determining op mal pharmacotherapeu c care plans for pa ents with hyperlipidemia.



Perform prac cal applica on of the new 2013 ACC/AHA Lipid Guidelines to pa ent care.



Apply principles of pharmacotherapy to management of pa ents with underlying disorders of HDL and triglyceride

metabolism.



Contrast the current recommenda ons of American Diabetes Associa on, American Academy of Clinical Endocrinologists, and

the Na onal Kidney Founda on for management of hyperlipidemia to the new 2013 ACC/AHA Lipid Guidelines.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐193‐L01‐P

Pour Some Sugar on Me  Diabetes Updates for the Prac cing Pharmacist  

Karen R. Sando, Pharm.D., BCACP, CDE, Clinical Assistant Professor, Area Health Educa on Centers (AHEC) Pharmacy Coordinator, Department of Pharmacotherapy & Transla onal Research, University of Florida College of Pharmacy, Gainesville, FL

Presenta on Objec ves:

Explain updates to widely used guidelines for diabetes management (e.g. ADA 2014 guidelines; AACE Control Algorithm 2013).

Describe new therapeu c agents for management of diabetes mellitus and current role in therapy.

Describe new technologies (e.g. new con nuous glucose monitors, insulin pumps, apps) for management of diabetes mellitus.

Discuss recent clinical controversies in diabetes management and provide clinical pearls for naviga ng controversies in

prac ce.

Educational Sessions

Sa

tur

da

y, Augus

t 9, 2014

CRITICAL

CARE/EMERGENCY

MEDICINE

TRACK

ROOM:

INTERNAL

MEDICINE/AMBULATORY

CARE

TRACK

ROOM:

(11)

Moderator: Teresa Geide, Pharm.D., BCPS

4:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐194‐L01‐P

Are there rough seas ahead? Immuniza on Update and Clinical Pearls 

Lisa Clayville Mar n, PharmD, CDE ‐ Director, Healthy Living Program, Lake Buena Vista, FL Presenta on Objec ves:



Discuss controversies surrounding currently available vaccines.



Review current vaccine quality concerns.



Discuss status of vaccines in the pipeline.



Discuss clinical pearls with current vaccines.

Moderator: Elias Chahine, Pharm.D., BCPS (AQ‐ID)

2:30‐3:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐195‐L04‐P

How to be an Eec ve Preceptor? 

Angela M. Hill, Pharm.D., BCPP, Professor and Chair of Pharmacy Prac ce, USF College of Pharmacy, Tampa, FL

Presenta on Objec ves:



Iden fy the quali es of an effec ve preceptor for pharmacy students and residents.



Describe how to integrate learners into busy acute care and ambulatory care prac ces.



Describe how to give effec ve feedback to pharmacy students and residents using SUCCESS and ResiTrak.

3:30‐4:30pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐196‐L04‐P

You Can be a Clinical Scholar Too!   

Gary M. Levin, Pharm.D., BCPP, FCCP, Vice President of Educa on/Chief Academic Officer, Dean, College of Pharmacy, Larkin Community Hospital, South Miami, FL

Presenta on Objec ves:



Discuss Boyer’s Model of Scholarship.



Describe the process of medical wri ng from idea genera on to publishing a manuscript in a peer‐review journal.



Provide examples on how to integrate pharmacy students and residents into research and scholarship.

3:30‐4:45pm BREAK

4:45‐5:45pm (1.0 hour of C.E. GCE/CRC) ACPE UAN 0163‐0000‐14‐197‐L04‐P

Interpre ng the Medical Literature   

Ashley Johnson, Pharm.D., BCPS, Assistant Professor of Pharmacy Prac ce, Drug Informa on Co‐Coordinator, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlan c University, West Palm Beach, FL

Krisy Thornby, Pharm.D., Assistant Professor of Pharmacy Prac ce, Drug Informa on Co‐Coordinator, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlan c University, West Palm Beach, FL

Presenta on Objec ves:



Review the advantages and disadvantages of superiority and non‐inferiority study designs in the medical literature.



Highlight the most commonly used sta s cal tests in the medical literature.



Calculate the odds ra o, the hazard, ra o, the number needed to treat and the number needed to harm using two clinical

trials as examples.



Explain the difference between clinical versus sta s cal significance.

Educational Sessions

Sa

tur

da

y, Augus

t 9, 2014

INTERNAL MEDICINE/AMBULATORY CARE TRACK,

CONT. ROOM:

(12)

Moderator: Chris ne Gegeckas, RPh, BCOP

7:00‐8:00am (1.0 hour of C.E. GCE/Tech) ACPE UAN 0163‐0000‐14‐198‐L04‐P and 0163‐0000‐14‐198‐L04‐T

Paul Rozzero, Pharm.D., Clinical Pain Management Specialist, Orlando Veterans' Administra on Medical Center, Orlando, FL Kenneth D. Hughes, Pharm.D., BCPS, Clinical Pharmacy Specialist, Orlando Veterans' Administra on Medical Center, Orlando, FL

Presenta on Objec ves:



Discuss how prescrip ons for controlled substances are monitored throughout the United States.



Understand the role of the Florida Prescrip on Drug Monitoring Program (PDMP).



Learn how to access and use Electronic‐Florida Online Repor ng of Controlled Substances Evalua on (E‐FORCSE).

Moderator: Jamie Kisgen, Pharm.D., BCPS

8:15‐9:15am (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐199‐L04‐P and 0163‐0000‐14‐199‐L04‐T

Naviga ng New Pharmacy Roles: A Spotlight on Popula on Health Management 

Michael Mustard, RPh, Clinical Quality Specialist, Health First Health Plans, Rockledge, FL

Presenta on Objec ves:



Introduce the principles of popula on health management and contrast them to the acute care se ng of health management.



Describe poten al impacts of popula on health management on health systems based pharmacy.



Discuss current and emerging roles for pharmacy prac oners in popula on health management.



Speculate on the future of popula on health management.

9:15‐10:15am (1.0 hour of C.E. GCE/CRC/Tech) ACPE UAN 0163‐0000‐14‐200‐L04‐P and 0163‐0000‐14‐200‐L04‐T

Ask the Expert Panel:   

ASHPChristene Jolowsky, MS, RPh, FASHP, Execu ve Director, Applied and Experien al Educa on, University of Minnesota College of

Pharmacy, Minnesota, MN/ASHP President

 

Board of Pharmacy/797Mark Mikhael, Pharm.D., Vice President of Opera ons, ProHealth Pharmacy Solu ons, Orlando, FL/Member, Florida Board of Pharmacy

Legisla veLawrence Gonzalez, Esq., General Counsel, Florida Society of Health‐System Pharmacists

 

College of PharmacyUniversity of FloridaKris n Weitzel, Pharm.D., CDE, FAPhA, Associate Director, UF Health Personalized Medicine Program, Clinical Associate Professor, Pharmacotherapy and Transla onal Research, University of Florida College of Pharmacy, Gainesville, FL

 

College of PharmacyUniversity of South FloridaKevin Sneed, Pharm.D., Senior Associate Vice President, USF Health, Dean & Professor, USF College of Pharmacy, Tampa, FL

Presenta on Objec ves:



List the top issues the Florida Board of Pharmacy foresees focusing on in the next year.



List the top priori es for ASHP in the coming year.



Provide ways for pharmacists to become aware and involved in pharmacy related legisla ve issues.



Discuss future direc ons for colleges of pharmacy.

10:15‐10:30am BREAK

10:30am‐12:30pm (2.0 hours of C.E. GCE/Med Errors/CRC/Tech) ACPE UAN 0163‐0000‐14‐201‐L05‐P and 0163‐0000‐14‐201‐L05‐T

Medica on Safety Tools for Error Preven on 

Lisa Zumberg, Pharm.D., Quality Assurance/Medica on Safety Manager, Department of Veterans Affairs, Gainesville, FL

Presenta on Objec ves:



Define Root Cause Analysis (RCA) and apply this process to a case study.



Define and classify medica on errors.



Discuss the impact that electronic prescribing systems have on medica on error reduc on and preven on.



Iden fy the importance of establishing a culture of safety within a system.

Educational Sessions

Sunda

y, Augus

t 10, 2014

M

T

E

FORCSE B W

Y

!

R :

PHARMACY PRACTICE/EMERGING OPPORTUNITIES TRACK

ROOM:

(13)

Programming that is accredited for pharmacy technicians has been indicated with ‘Tech’ designa on. The following presenta ons in the Pharmacist Tracks on Friday include objec ves appropriate for pharmacy technicians: Keynote, Sterile Compounding Track, Future Leaders Track. The Pharmacy Law Update Panel on Saturday and all of the presenta ons on

Sunday are appropriate for pharmacy technicians.

Below are Technician–Specific Sessions, only accredited for Pharmacy Technicians.

3:30‐5:45pm (2.0 hours of C.E. Tech) ACPE UAN 0163‐0000‐14‐202‐L04‐T

Technician Discussion Forum 

Forum Facilitators: Sheryl MacKenzie, RPhT, CPhT, Senior Purchasing Coordinator, Town and Country Hospital, Tampa, FL

Roma Merrick, RPhT, CPhT, Pharmacy Technician Coordinator, St. Vincent’s Medical Center‐Southside,

Jacksonville, FL

Presenta on Objec ves:



Review the roles and responsibili es of being a preceptor.



Explain the causes of burnout and how to prevent it.



Describe how the changing roles for technicians can impact career development and career advancement.



Explain the role of technicians in the pharmacy profession.

Space is limited to Pharmacy Technicians who indicated their interest in a ending during mee ng pre‐registra on.

Moderators: Sheryl MacKenzie, RPhT, CPhT and Roma Merrick, RPhT, CPhT

8:15‐10:30am (2.0 hours of C.E. Tech) ACPE UAN 0163‐0000‐14‐203‐L04‐T

Sterile Compounding Update 

Mark Mikhael, Pharm.D., Vice President of Opera ons, ProHealth Pharmacy Solu ons/Member, Florida Board of Pharmacy, Orlando, FL

Presenta on Objec ves:



Highlight the New England Compounding Center tragedy and its implica ons in Florida.



Review the results of the mandatory compounding survey report .



Discuss development and implementa on of Special Sterile Compounding Permit 64B16‐28.800.



Summarize Florida Board of Pharmacy workshops regarding 64B16‐27.797 and sterile compounding.



Iden fy current USP 797 standards and related chapters as it relates to compliance in Florida for October 2014.

10:30‐11:30am (1.0 hour of C.E. Tech) ACPE UAN 0163‐0000‐14‐204‐L04‐T

Safe Handling of Hazardous Medica ons 

Melissa Butler, Pharm.D., BCOP, Clinical Pharmacy Specialist, UF Health Cancer Center at Orlando Health, Orlando, FL

Presenta on Objec ves:



Recognize agents classified as hazardous medica ons.



Discuss the risks associated with accidental exposure to hazardous medica ons.



List the various stages during handling of chemotherapy when accidental exposure can occur.



Describe methods u lized to decrease accidental exposure of hazardous medica ons.

1:30‐2:30pm (1.0 hour of C.E. Tech) ACPE UAN 0163‐0000‐14‐205‐L04‐T

New and Uncommon Drugs 

Alexis Berndt, Pharm.D., BCPS, Clinical Pharmacist, Health First Viera Hospital , Melbourne, FL Presenta on Objec ves:



Explain new medica ons and unique dosage forms recently FDA approved.



Compare newer medica ons with exis ng similar agents regarding prepara on, safety considera ons and cost.



Discuss older and uncommon medica ons with significant prepara on, safety or storage and handling requirements.

2:30‐3:30pm (1.0 hour of C.E. Tech) ACPE UAN 0163‐0000‐14‐206‐L04‐T

A Review of Pharmacy Calcula ons for Pharmacy Technicians 

Nina Pavuluri, PhD, Assistant Professor of Pharmaceu cs, Director of Admissions, LECOM Bradenton School of Pharmacy, Bradenton, FL

Presenta on Objec ves:



Review conversion of measurements within the metric systems of weight and volume.



Discuss ra o and propor on, percentage, dilu on and concentra on, mill‐equivalent, units, intravenous flow rates, and

solving dosage problems.



Review reading, interpre ng, and solving calcula on problems encountered in the prepara on and distribu on of drugs.

Educational Sessions

Te

chnician

Speci

fi

c Pr

ogr

amming

FRIDAY, AUGUST 8, 2014

ROOM:

(14)

3:30‐4:30pm (1.0 hour of C.E. Tech) ACPE UAN 0163‐0000‐14‐207‐L01‐T

Infec on Preven on 

Florian Daragja , Pharm.D., BCPS, Pharmacy Clinical Manager, St. Vincent’s Medical Center‐Southside, Jacksonville, FL

Presenta on Objec ves:



Describe the role of isola on in preven ng the spread of certain infec ons.



Describe each type of isola on with examples of diseases and treatment op ons.



Explain the significance of correct sequence of donning and removing personal protec ve equipment (PPE).



Describe the significance of an bio c resistant organisms seen in hospitals.

4:45‐5:45pm (1.0 hour of C.E. Tech) ACPE UAN 0163‐0000‐14‐208‐L04‐T

Medica on Diversion 

Charze a James, Pharm.D., CPh, MBA, MHA, FACHE, System Director of Pharmacy, St. Vincent’s HealthCare, Jacksonville, FL

Presenta on Objec ves:



Define and discuss drug diversion/drug abuse.



Iden fy symptoms associated with impaired prac oners in the workplace.



Discuss alarming sta s cs associated with drug diversion.



Iden fy common drugs of abuse.



Discuss prescrip on drug abuse.



Discuss the effects of drug diversion on pa ent safety and pa ent care.



Share successful processes and strategies.

STATE REGISTRATION

Florida registered technicians are required to obtain twenty (20) hours of approved courses of con nuing pharmacy educa on per biennial (24 month period). Four (4) of the twenty (20) hours of approved courses of con nuing pharmacy educa on must be LIVE con nuing

educa on hours. LIVE con nuing educa on is defined as either a live mee ng, a live video teleconference, or through an interac ve

web‐based applica on.

Next Renewal Date: December 31, 2014

MEDICATION ERRORS CONTINUING EDUCATION REQUIREMENTS

As a part of the biennial renewal, pharmacy technicians are required to complete a two (2) hour Florida Board of Pharmacy approved course on Medica on Errors. The course must contain the following components: (a) root‐cause analysis; (b) error reduc on and preven on; (c) pa ent safety. The two (2) hour program may be applied towards the twenty (20) hours of required con nuing educa on for Florida registered technicians

HIV/AIDS CONTINUING EDUCATION REQUIREMENTS

Applicants for registra on renewal are no longer required to show proof of a course on HIV/AIDS as part of the registra on renewal process.

UPON A TECHNICIAN’S FIRST RENEWAL OF REGISTRATION, the technician must document the comple on of one (1) hour of a Board

approved HIV/AIDS con nuing educa on credit. The topics must include: Human Immunodeficiency Virus and Acquired Immune Deficiency

Syndrome; the modes of transmission, including transmission from a healthcare worker to a pa ent and the pa ent to the healthcare worker; infec on control procedures, including universal precau ons; epidemiology of the disease; related infec ons including tuberculosis

(TB); clinical management; preven on; and current Florida law on AIDS and its impact on tes ng, confiden ality of test results, and

treatment of pa ents. In order to meet this requirement, licensees must demonstrate that the course includes informa on on the State of

Florida law on HIV/AIDS and its impact on tes ng, repor ng, the offering of HIV tes ng to pregnant women, and partner no fica on issues

pursuant to Sec ons 381.004 and 384.25, Florida Statutes. Any HIV/AIDS con nuing educa on course taken during the second or subsequent renewal of licensure may be applied to sa sfy the general con nuing educa on hours requirement.

NATIONAL CERTIFICATION THROUGH PTCB

Cer fied Pharmacy Technicians must complete a minimum of twenty (20) hours of con nuing educa on in pharmacy‐related subject ma er

during each two (2) year re‐cer fica on cycle. For recer fica on candidates, one (1) hour of the twenty (20) hours must be in the subject of

pharmacy law and one (1) hour must be in the subject of *pa ent safety (refer to Accredita on Council for Pharmacy Educa on (ACPE)

defini on of pa ent safety.

Read more at www.ptcb.org

*The Medica on Errors courses offered on Friday and Sunday will sa sfy the pa ent safety requirement.

Educational Sessions

Te

chnician

Speci

fi

c Pr

ogr

amming

PHARMACY TECHNICIAN CONTINUING EDUCATION REQUIREMENTS

16

(15)

Moderators: Renee Rose, Pharm.D. and Jonathan Girnys, Pharm.D.

8:00‐9:15am

FSHP Quiz Bowl 

Come and support your FSHP Quiz Bowl which consists of a 3‐person team from each School/College of Pharmacy. The format of the Quiz Bowl is Jeopardy style with 5 categories with 5 different values, Double Jeopardy with 5 categories with 5 different values, and Final Jeopardy rounds. You won’t want to miss this compe on! 

Quiz Bowl Teams:



Florida A & M University: Porschia Jordan, Kenneth Joseph, Shanada Thomas



Lake Erie College of Osteopathic Medicine‐Bradenton: Mark LaBossiere, Hillary Silvestri, John Phillips IV



Nova Southeastern University: Ma hew Brooks, Ravin Seewah, Michael Drake



Palm Beach Atlan c University: Angela Skaff, Nick Palm, Jillian DeGuzman



University of Florida: Michael Napoleon, Stanley Luc, Mark Priddy



University of South Florida: Mohammed Abdulwahhab, Danielle Moore, Julie Krapfel

9:30‐11:00am

Residency Roundtable 

Pharmacy students...interested in doing a residency?! This is a great opportunity for to sit and talk with PGY‐2 residents to ask ques ons and find out what residencies are looking for in applicants. Also remember to visit the Residency Showcase from 1:00‐2:30pm.

Roundtable par cipants:

Lauren Rios, PGY‐2 Drug Informa on, UF Health, Jacksonville, FL



Jonathan Girnys, PGY‐2 Pharmacy Administra on Resident, Lee Memorial Health System, Ft. Myers, FL



Joseph Trang, PGY‐2 Cri cal Care, Orlando Regional Medical Center, Orlando, FL



Kayla Montgomery, PGY‐2 Emergency Medicine, Lakeland Regional Medical Center, Lakeland, FL



Kirsten Busey, PGY‐2 Emergency Medicine, UF Health, Jacksonville, FL



Sarah Onofrio, PGY‐2 Pain/Pallia ve Care, West Palm Beach VA, West Palm Beach, FL



Jonathan Cho, PGY‐2 Infec ous Diseases, Lee Memorial Health System, Ft. Myers



Fei Wang, PGY‐2 Pharmacy Prac ce Resident, Cleveland Clinic, Weston, FL



Duchess Domingo, PGY‐1 Pharmacy Prac ce Resident, Broward Health Medical Center, Ft. Lauderdale, FL

11:00‐11:30am

Pharmacy Prac ce Model Ini a ve Update 

Osmel Delgado, Pharm.D., MBA, FASHP, Senior Director of Opera ons, Cleveland Clinic, Weston, FL 2:30‐3:30pm

You are the Future: Steer Your Ship 

Connie Hogrefe, Pharm.D., Pharmacist, Lee Memorial Health System‐Lee Pharmacy, Ft. Myers, FL 3:30‐4:30pm

Leadership 

John A. Armitstead, MS, RPh, FASHP, System Director of Pharmacy Services, Lee Memorial Health System, Fort Myers and Cape Coral, FL James C. McAllister III, MS, FASHP, Regional Experien al Program Coordinator, University of Florida College of Pharmacy, Ft. Myers, FL 4:45‐5:45pm

Career Panel:

Career Opportuni es in Industry 

Rena Coll, Pharm.D., Director, Medical Outcomes Specialist, Pfizer, Coral Springs, FL  

A Day in the Life of a Medica on Safety Pharmacist 

Kelly Biastre, Pharm.D., Senior Consultant Medica on Safety, Bap st Medical Center, Jacksonville, FL

     

Career Opportuni es in Informa cs

Darshika Patel, Pharm.D., BCPS, Clinical Informa cs Pharmacist, Department of Pharmacy, Cleveland Clinic, Weston, FL  

Home Infusion Pharmacy

Jennifer Palladino, RPh, Pharmacy Manager, Health First Infusion, Orlando, FL  

Emergency Medicine 

Kathryn Samai, Pharm.D., BCPS, Assistant Professor of Pharmacy Prac ce, LECOM Bradenton School of Pharmacy, Bradenton, FL

Pharmacy Student Track

Studen

t Pr

ogr

amming

Figure

Updating...

References

Related subjects :